Appointment

CellCentric appoints experienced oncology leaders  

6 April 2022

Biotechnology company CellCentric has strengthened its leadership team with two new appointments. The company has appointed Kris Frese as Director of Cancer Biology, and Andrew Hughes, who joins the Board as a Non-Executive Director.   Kris Frese is an experienced cancer biologist who specialises in models of cancer and biomarker analysis. Frese most recently served as […]